First Header Logo Second Header Logo

The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function.

Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004 Sep 01; 64(17):6344-8.

View in: PubMed